African-American patients also have a greater prevalence of more aggressive, poorly differentiated, estrogen-receptor (ER)-negative tumors and a higher rate of lymph node involvement than European-Americans [4], [5], and they develop breast cancer at an age younger than 35 twice as frequently as European-American women [9]. Here, ESR1 is linked to breast carcinoma.